| Cas No.: | 1226895-20-0 |
| Chemical Name: | ATB 346 |
| Synonyms: | ATB 346;(4-carbamothioylphenyl) 2-(6-methoxynaphthalen-2-yl)propanoate;ATB-346;UNII-3096O7WP53;6-Methoxy-alpha-methyl-2-naphthaleneacetic acid 4-(aminothioxomethyl)phenyl ester |
| SMILES: | COC1=CC=C(C=C(C(C)C(OC2=CC=C(C(N)=S)C=C2)=O)C=C3)C3=C1 |
| Formula: | C21H19NO3S |
| M.Wt: | 365.44546 |
| Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | ATB-346 is a novel hydrogen sulphide-releasing derivative of naproxen with markedly reduced toxicity. IC50 value: Target: COX-2 ATB-346 suppressed gastric prostaglandin E(2) synthesis as effectively as naproxen, but produced negligible damage in the stomach and intestine, Unlike naproxen and celecoxib, ATB-346 accelerated healing of pre-existing gastric ulcers. In a mouse airpouch model, ATB-346 suppressed cyclooxygenase-2 activity and inhibited leukocyte infiltration more effectively than naproxen. ATB-346 was as effective as naproxen in adjuvant-induced arthritis in rats, with a more rapid onset of activity. Unlike naproxen, ATB-346 did not elevate blood pressure in hypertensive rats . Treatement with ATB-346 exhibited a significantly more rapid and sustained recovery of motor function, achieving greater than double the increase in locomotion score of the naproxen group by the 10th day of treatment. ATB-346 also significantly reduced the severity of inflammation (proinflammatory cytokines, apoptosis of neural tissue, and nitrosative stress) that characterized the secondary effects of SCI .For the detailed information of ATB-346, the solubility of ATB-346 in water, the solubility of ATB-346 in DMSO, the solubility of ATB-346 in PBS buffer, the animal experiment (test) of ATB-346, the cell expriment (test) of ATB-346, the in vivo, in vitro and clinical trial test of ATB-346, the EC50, IC50,and Affinity of ATB-346, Please contact DC Chemicals. |

To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
